Stericycle, Inc. (NASDAQ:SRCL), today reported financial results for the fourth quarter and full year of 2013.
Revenues for the quarter ended December 31, 2013 were $567.9 million, up 12.8% from $503.6 million in the fourth quarter last year. Acquisitions contributed approximately $32.4 million to the current period’s growth in revenues. Revenues increased 13.8% compared to the prior period when adjusted for unfavorable foreign exchange impacts of $5.4 million. Gross profit was $253.3 million, up 11.6% from $227.0 million in the fourth quarter last year. Gross profit as a percent of revenues was 44.6% compared with 45.1% in the fourth quarter of 2012. Earnings per diluted share, reported in accordance with U.S. generally accepted accounting principles (“GAAP”), increased 11.8% to $0.90 from $0.80 in the fourth quarter of 2012. Non-GAAP earnings per diluted share, when adjusted for various items identified in the second of the following tables, increased 10.8% to $0.99 from $0.89. See tables below.
FULL-YEAR RESULTS
Revenues for the full year 2013 were $2.14 billion, up 12.0% from $1.91 billion in 2012. Acquisitions contributed approximately $137.6 million to the current year’s growth in revenues. Revenues increased 13.0% compared to the prior year when adjusted for unfavorable foreign exchange impacts of $19.0 million. Gross profit was $964.6 million, up 12.5% from $857.3 million in 2012. Gross profit as a percent of revenues was 45.0% compared with 44.8% in 2012. GAAP earnings per diluted share increased 15.7% to $3.56 from $3.08 in 2012. Non-GAAP earnings per diluted share, when adjusted for various items identified in the second of the following tables, increased 12.4% to $3.75 from $3.34. See tables below.
The following table shows our calculations of organic revenue growth (in millions)(1):
| Three Months Ended December 31, | Years Ended December 31, | |||||||||||||||||||||||||||||
| Change | Change | |||||||||||||||||||||||||||||
| 2013 | 2012 | $ | % | 2013 | 2012 | $ | % | |||||||||||||||||||||||
| Total As Reported Revenues (GAAP) | $ | 567.9 | $ | 503.6 | $ | 64.3 | 12.8 | % | $ | 2,142.8 | $ | 1,913.1 | $ | 229.7 | 12.0 | % | ||||||||||||||
| Adjustment for Foreign Exchange | 5.4 | - | 5.4 | 19.0 | - | 19.0 | ||||||||||||||||||||||||
| Subtotal (non-GAAP): | 573.3 | 503.6 | 69.7 | 13.8 | % | 2,161.8 | 1,913.1 | 248.7 | 13.0 | % | ||||||||||||||||||||
| Adjustment for Acquisitions | (40.4 | ) | (8.0 | ) | (32.4 | ) | (153.8 | ) | (16.2 | ) | (137.6 | ) | ||||||||||||||||||
|
Adjustment for Regulated Returns and
Recall Management Services | (26.4 | ) | (22.8 | ) | (3.6 | ) | (97.8 | ) | (116.3 | ) | 18.5 | |||||||||||||||||||
| Subtotal (non-GAAP): | $ | 506.5 | $ | 472.8 | $ | 33.7 | 7.1 | % | $ | 1,910.2 | $ | 1,780.6 | $ | 129.6 | 7.3 | % | ||||||||||||||
| Domestic/ International Breakdown: | ||||||||||||||||||||||||||||||
| Domestic Revenues | $ | 394.6 | $ | 355.5 | $ | 39.1 | 11.0 | % | $ | 1,506.6 | $ | 1,370.8 | $ | 135.8 | 9.9 | % | ||||||||||||||
| International Revenues | 173.3 | 148.1 | 25.2 | 17.0 | % | 636.2 | 542.3 | 93.9 | 17.3 | % | ||||||||||||||||||||
| Total As Reported Revenues (GAAP) | $ | 567.9 | $ | 503.6 | $ | 64.3 | 12.8 | % | $ | 2,142.8 | $ | 1,913.1 | $ | 229.7 | 12.0 | % | ||||||||||||||
(1) When evaluating organic revenue growth for internal purposes, we exclude (i) the impact of foreign exchange, (ii) revenues attributed to acquisitions closed within the preceding 12 months and (iii) revenues from our regulated returns and recall management services. This table and the Company’s internal use of non-GAAP adjusted revenues are not intended to imply, and should not be interpreted as implying, that non-GAAP adjusted revenues are a better measure of internal growth or the Company’s performance than GAAP revenues.
Table to reconcile GAAP EPS to Non-GAAP EPS(2):
| Three Months Ended December 31, | Years Ended December 31, | |||||||||||||||||||||||||
| Change | Change | |||||||||||||||||||||||||
| 2013 | 2012 | $ | % | 2013 | 2012 | $ | % | |||||||||||||||||||
| GAAP EPS | $ | 0.90 | $ | 0.80 | $ | 0.09 | 11.8 | % | $ | 3.56 | $ | 3.08 | $ | 0.48 | 15.7 | % | ||||||||||
| Acquisition and Integration Expenses | 0.07 | 0.03 | 0.17 | 0.13 | ||||||||||||||||||||||
| Change in Fair Value of Contingent Consideration | (0.02 | ) | 0.00 | (0.03 | ) | 0.01 | ||||||||||||||||||||
| Restructuring, Plant Closure, and Change in Fair Value of Assets | 0.03 | 0.01 | 0.03 | 0.04 | ||||||||||||||||||||||
| Loss on Sale of Business | - | - | - | 0.04 | ||||||||||||||||||||||
| Litigation Settlement | 0.01 | 0.04 | 0.02 | 0.04 | ||||||||||||||||||||||
| Non-GAAP EPS (Adjusted) | $ | 0.99 | $ | 0.89 | $ | 0.10 | 10.8 | % | $ | 3.75 | $ | 3.34 | $ | 0.41 | 12.4 | % | ||||||||||
(2) In accordance with GAAP, reported earnings per share (EPS) include the after-tax impact of the items identified in this table. For internal purposes, including the determination of management compensation, the Company excludes these items from results when evaluating operating performance. This table and the Company’s internal use of non-GAAP earnings per share are not intended to imply, and should not be interpreted as implying, that non-GAAP earnings per share is a better measure of performance than GAAP earnings per share.
Cash flow from operations was $403.5 million and $387.4 million for the full years of 2013 and 2012, respectively.
For more information about Stericycle, please visit our website at www.stericycle.com.
CONFERENCE CALL
Conference call to be held February 5, 2014 4:00 p.m. Central time – Dial 866-516-6872 at least 5 minutes before start time. If you are unable to participate on the call, a replay will be available through March 5th by dialing 855-859-2056, access code 13894327. To hear a live simulcast of the call over the internet on www.earnings.com, or to access an audio archive of the call, go to the Investors page on Stericycle’s website at www.stericycle.com.
Safe Harbor Statement: Statements in this press release may contain forward-looking statements that involve risks and uncertainties, some of which are beyond our control (for example, general economic conditions). Our actual results could differ significantly from the results described in the forward-looking statements. Factors that could cause such differences include changes in governmental regulation of medical waste collection and treatment and increases in transportation and other operating costs, as well as the other factors described in our filings with the U.S. Securities and Exchange Commission. As a result, past financial performance should not be considered a reliable indicator of future performance, and investors should not use historical trends to anticipate future results or trends. We make no commitment to disclose any subsequent revisions to forward-looking statements.
| STERICYCLE, INC. AND SUBSIDIARIES | ||||||
| CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||
| (IN THOUSANDS) | ||||||
| December 31, | ||||||
| 2013 | 2012 | |||||
| (Unaudited) | (Audited) | |||||
| ASSETS | ||||||
| Current Assets: | ||||||
| Cash and cash equivalents | $ | 61,991 | $ | 31,324 | ||
| Short-term investments | 413 | 503 | ||||
| Accounts receivable, net | 388,996 | 322,246 | ||||
| Deferred income taxes | 18,031 | 22,995 | ||||
| Prepaid expenses | 28,379 | 27,042 | ||||
| Other current assets | 37,279 | 37,176 | ||||
| Total Current Assets | 535,089 | 441,286 | ||||
| Property, plant and equipment, net | 358,967 | 335,870 | ||||
| Goodwill | 2,231,582 | 2,065,103 | ||||
| Intangible assets, net | 720,035 | 667,471 | ||||
| Other assets | 37,124 | 37,008 | ||||
| Total Assets | $ | 3,882,797 | $ | 3,546,738 | ||
| LIABILITIES AND EQUITY | ||||||
| Current Liabilities: | ||||||
| Current portion of long-term debt | $ | 150,380 | $ | 87,781 | ||
| Accounts payable | 89,146 | 80,886 | ||||
| Accrued liabilities | 107,445 | 115,992 | ||||
| Deferred revenues | 18,826 | 18,095 | ||||
| Other current liabilities | 45,211 | 28,306 | ||||
| Total Current Liabilities | 411,008 | 331,060 | ||||
| Long-term debt, net of current portion | 1,280,663 | 1,268,303 | ||||
| Deferred income taxes | 396,119 | 359,780 | ||||
| Other liabilities | 27,469 | 30,272 | ||||
| Equity: | ||||||
| Common stock | 855 | 860 | ||||
| Additional paid-in capital | 195,110 | 116,720 | ||||
| Accumulated other comprehensive loss | (56,467) | (39,064) | ||||
| Retained earnings | 1,610,963 | 1,463,277 | ||||
| Total Stericycle, Inc. Equity | 1,750,461 | 1,541,793 | ||||
| Noncontrolling interests | 17,077 | 15,530 | ||||
| Total Equity | 1,767,538 | 1,557,323 | ||||
| Total Liabilities and Equity | $ | 3,882,797 | $ | 3,546,738 | ||
| STERICYCLE, INC. AND SUBSIDIARIES | |||||||||||||||||||||||||||
| CONDENSED CONSOLIDATED STATEMENTS OF INCOME | |||||||||||||||||||||||||||
| (IN THOUSANDS EXCEPT SHARES AND PER SHARE DATA) | |||||||||||||||||||||||||||
| Three Months Ended | Years Ended | ||||||||||||||||||||||||||
| December 31, | December 31, | ||||||||||||||||||||||||||
| 2013 | 2012 | 2013 | 2012 | ||||||||||||||||||||||||
| (Unaudited) | (Unaudited) | (Audited) | |||||||||||||||||||||||||
| $ | % of Rev | $ | % of Rev | $ | % of Rev | $ | % of Rev | ||||||||||||||||||||
| Revenues | $ | 567,899 | 100.0 | % | $ | 503,638 | 100.0 | % | $ | 2,142,807 | 100.0 | % | $ | 1,913,149 | 100.0 | % | |||||||||||
| Cost of revenues (exclusive of depreciation shown below) | 299,347 | 52.7 | % | 264,541 | 52.5 | % | 1,126,050 | 52.6 | % | 1,011,081 | 52.8 | % | |||||||||||||||
| Depreciation - cost of revenues | 13,147 | 2.3 | % | 12,009 | 2.4 | % | 50,003 | 2.3 | % | 44,631 | 2.3 | % | |||||||||||||||
| Litigation settlement and restructuring costs | 2,120 | 0.4 | % | 132 | 0.0 | % | 2,120 | 0.1 | % | 132 | 0.0 | % | |||||||||||||||
| Total cost of revenues | 314,614 | 55.4 | % | 276,682 | 54.9 | % | 1,178,173 | 55.0 | % | 1,055,844 | 55.2 | % | |||||||||||||||
| Gross profit | 253,285 | 44.6 | % | 226,956 | 45.1 | % | 964,634 | 45.0 | % | 857,305 | 44.8 | % | |||||||||||||||
| Selling, general and administrative expenses | |||||||||||||||||||||||||||
| (exclusive of depreciation and amortization below) | 99,728 | 17.6 | % | 86,496 | 17.2 | % | 372,091 | 17.4 | % | 327,131 | 17.1 | % | |||||||||||||||
| Depreciation - SG&A | 2,965 | 0.5 | % | 2,706 | 0.5 | % | 11,338 | 0.5 | % | 9,598 | 0.5 | % | |||||||||||||||
| Amortization | 7,183 | 1.3 | % | 6,379 | 1.3 | % | 27,067 | 1.3 | % | 22,054 | 1.2 | % | |||||||||||||||
| Total SG&A expense | 109,876 | 19.3 | % | 95,581 | 19.0 | % | 410,496 | 19.2 | % | 358,783 | 18.8 | % | |||||||||||||||
| Income from operations before | |||||||||||||||||||||||||||
| acquisition, integration, and other expenses | 143,409 | 25.3 | % | 131,375 | 26.1 | % | 554,138 | 25.9 | % | 498,522 | 26.1 | % | |||||||||||||||
| Acquisition and integration expenses | 6,856 | 1.2 | % | 3,063 | 0.6 | % | 16,796 | 0.8 | % | 12,816 | 0.7 | % | |||||||||||||||
| Change in fair value of contingent consideration | (1,971 | ) | -0.3 | % | 161 | 0.0 | % | (2,278 | ) | -0.1 | % | 752 | 0.0 | % | |||||||||||||
| Litigation settlement | - | 0.0 | % | 6,050 | 1.2 | % | 116 | 0.0 | % | 6,050 | 0.3 | % | |||||||||||||||
| Restructuring, plant closure, and change in fair value of assets | 3,417 | 0.6 | % | 1,801 | 0.4 | % | 3,885 | 0.2 | % | 5,201 | 0.3 | % | |||||||||||||||
| Loss on sale of business | - | 0.0 | % | - | 0.0 | % | - | 0.0 | % | 4,867 | 0.3 | % | |||||||||||||||
| Income from operations | 135,107 | 23.8 | % | 120,300 | 23.9 | % | 535,619 | 25.0 | % | 468,836 | 24.5 | % | |||||||||||||||
| Other income (expense): | |||||||||||||||||||||||||||
| Interest expense (net) | (15,341 | ) | -2.7 | % | (13,006 | ) | -2.6 | % | (54,949 | ) | -2.6 | % | (51,270 | ) | -2.7 | % | |||||||||||
| Other expense, net | (25 | ) | 0.0 | % | 187 | 0.0 | % | (2,924 | ) | -0.1 | % | (369 | ) | 0.0 | % | ||||||||||||
| Total other expense | (15,366 | ) | -2.7 | % | (12,819 | ) | -2.5 | % | (57,873 | ) | -2.7 | % | (51,639 | ) | -2.7 | % | |||||||||||
| Income before income taxes | 119,741 | 21.1 | % | 107,481 | 21.3 | % | 477,746 | 22.3 | % | 417,197 | 21.8 | % | |||||||||||||||
| Income tax expense | 41,154 | 7.2 | % | 36,973 | 7.3 | % | 164,662 | 7.7 | % | 147,256 | 7.7 | % | |||||||||||||||
| Net income | 78,587 | 13.8 | % | 70,508 | 14.0 | % | 313,084 | 14.6 | % | 269,941 | 14.1 | % | |||||||||||||||
| Less: net income attributable to noncontrolling interests | 423 | 0.1 | % | 439 | 0.1 | % | 1,712 | 0.1 | % | 1,945 | 0.1 | % | |||||||||||||||
| Net income attributable to Stericycle, Inc. | $ | 78,164 | 13.8 | % | $ | 70,069 | 13.9 | % | $ | 311,372 | 14.5 | % | $ | 267,996 | 14.0 | % | |||||||||||
| Earnings per share - diluted | $ | 0.90 | $ | 0.80 | $ | 3.56 | $ | 3.08 | |||||||||||||||||||
| Weighted average number of | |||||||||||||||||||||||||||
| common shares outstanding - diluted | 87,107,437 | 87,281,680 | 87,391,988 | 87,018,473 | |||||||||||||||||||||||
| STERICYCLE, INC. AND SUBSIDIARIES | ||||||||
| CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||
| (IN THOUSANDS) | ||||||||
| Years Ended December 31, | ||||||||
| 2013 | 2012 | |||||||
| (Unaudited) | (Audited) | |||||||
| Operating Activities: | ||||||||
| Net income | $ | 313,084 | $ | 269,941 | ||||
| Adjustments to reconcile net income to net cash | ||||||||
| provided by operating activities: | ||||||||
| Loss on sale of business | - | 4,867 | ||||||
| Restructuring, plant closure, and change in fair value of assets | 3,381 | 1,677 | ||||||
| Change in fair value of contingent consideration | (2,278 | ) | 752 | |||||
| Stock compensation expense | 17,457 | 16,339 | ||||||
| Excess tax benefit of stock options exercised | (17,153 | ) | (30,161 | ) | ||||
| Depreciation | 61,341 | 54,229 | ||||||
| Amortization | 27,067 | 22,054 | ||||||
| Deferred income taxes | 30,930 | 22,678 | ||||||
| Changes in operating assets and liabilities, net of | ||||||||
| effect of acquisitions and divestitures: | ||||||||
| Accounts receivable | (54,767 | ) | (4,329 | ) | ||||
| Accounts payable | 7 | 406 | ||||||
| Accrued liabilities | 4,547 | 24,537 | ||||||
| Deferred revenue | (1,319 | ) | 931 | |||||
| Other assets and liabilities | 21,170 | 3,527 | ||||||
| Net cash provided by operating activities | 403,467 | 387,448 | ||||||
| Investing Activities: | ||||||||
| Payments for acquisitions, net of cash acquired | (161,936 | ) | (224,367 | ) | ||||
| Proceeds from/ (purchases of) short-term investments | 73 | (89 | ) | |||||
| Proceeds from sale of business and other assets | - | 764 | ||||||
| Capital expenditures | (73,109 | ) | (65,236 | ) | ||||
| Net cash used in investing activities | (234,972 | ) | (288,928 | ) | ||||
| Financing Activities: | ||||||||
| Net repayment of long-term debt and other obligations | (88,507 | ) | (102,932 | ) | ||||
| Net borrowing on foreign bank debt | 17,001 | 29,166 | ||||||
| Net borrowing/ (repayment) on senior credit facility | 44,739 | (304,309 | ) | |||||
| Proceeds from private placement of long-term note | - | 250,000 | ||||||
| Payments of deferred financing costs | - | (956 | ) | |||||
| Payments on capital lease obligations | (4,024 | ) | (3,192 | ) | ||||
| Purchase and cancellation of treasury stock | (163,700 | ) | (48,028 | ) | ||||
| Proceeds from issuances of common stock | 42,345 | 64,461 | ||||||
| Excess tax benefit of stock options exercised | 17,153 | 30,161 | ||||||
| Payments to noncontrolling interests | (1,026 | ) | (5,897 | ) | ||||
| Net cash used in financing activities | (136,019 | ) | (91,526 | ) | ||||
| Effect of exchange rate changes on cash | (1,809 | ) | 1,819 | |||||
| Net increase in cash and cash equivalents | 30,667 | 8,813 | ||||||
| Cash and cash equivalents at beginning of period | 31,324 | 22,511 | ||||||
| Cash and cash equivalents at end of period | $ | 61,991 | $ | 31,324 | ||||
| Non-cash activities: | ||||||||
| Net issuances of obligations for acquisitions | $ | 100,101 | $ | 97,541 | ||||
| Net issuances of obligations for noncontrolling interest | 6,119 | 8,197 | ||||||
Contacts:
Frank ten Brink, 847-607-2012
